UF
ACHN

Univest Financial’s Achillion Pharmaceuticals ACHN Stock Holding History

Univest Financial’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-16,980
Closed -$61K – 136
2019
Q3 		$61K Hold
16,980
– – 0.02% 109
2019
Q2 		$46K Hold
16,980
– – 0.01% 108
2019
Q1 		$50K Hold
16,980
– – 0.02% 114
2018
Q4 		$27K Hold
16,980
– – 0.01% 112
2018
Q3 		$62K Buy
+16,980
New +$50.6K 0.02% 108

Other funds holding ACHN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Univest Financial's ACHN Position: Q4 2019 in Review

Univest Financial sold out of Achillion Pharmaceuticals (ACHN) in Q4 2019, closing a stake of 16,980 shares — an estimated $61K sold.

Univest Financial first reported a position in ACHN in Q3 2018 and held it in 5 quarters. The position peaked at $62K in Q3 2018. 132 funds tracked by Wall St. Rank hold ACHN as of Q4 2019.

  • Univest Financial reported no remaining Achillion Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Univest Financial sold 16,980 Achillion Pharmaceuticals shares in Q4 2019, an estimated $61K.
  • Univest Financial first reported a position in Achillion Pharmaceuticals in Q3 2018 and held it in 5 quarters.
  • Univest Financial's Achillion Pharmaceuticals position peaked at $62K in Q3 2018.
  • 132 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2019.

Based on Univest Financial's 13F filing for Q4 2019, filed 14 Jan 2020.